Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Neuroepidemiology|November 3, 2015
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PDStefanie Lerche, Inga Liepelt-Scarfone, Guido Alves, et al.Frontiers in Aging Neuroscience|July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedSebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.Journal of Parkinson'S Disease|October 3, 2025
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathiesIlham Y Abdi, Indulekha P Sudhakaran, Simona S Ghanem, et al.Lancet (London, England)|February 7, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trialNirosen Vijiaratnam, Christine Girges, Grace Auld, et al.Ebiomedicine|May 30, 2025
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderStephen Joza, Aline Delva, Christina Tremblay, et al.Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Convergent large-scale network and local vulnerabilities underlie brain atrophy across Parkinson's disease stages: a worldwide ENIGMA studyAndrew Vo, Christina Tremblay, Shady Rahayel, et al.Brain : a Journal of Neurology|February 22, 2019
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre studyRonald B Postuma, Alex Iranzo, Michele Hu, et al.NPJ Parkinson'S Disease|November 18, 2024
A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's diseaseMax A Laansma, Yuji Zhao, Eva M van Heese, et al.Pageof 3